Christina Tsai, Ph.D.

CMC Consultant at Aureli Biologics Solution

Speaker

Christina Tsai, Ph.D., is a biologics cell line development expert and entrepreneur with over 12 years of experience in biologics process development and cell line development, and 12 years of hands-on expertise applying next-generation sequencing (NGS) to advance biopharmaceutical innovation. She has held scientific leadership roles at EpiBiome, Henlius Biotech, Samsung Biologics, and IGM Biosciences, driving progress in cell line development and data-guided process optimization. She is the founder of Aureli Biologics Solution, a consulting firm focused on enabling next-generation biologics development strategies.